Malvinder Mohan Singh is an Indian businessman with Ranbaxy and Religare business. He is a former chairman and CEO of Ranbaxy Laboratories, an Indian pharmaceutical company that he sold to Japanese drugmaker Daiichi Sankyo, who resigned in 2009 after Ranbaxy posted losses and after Daiichi Sankyo decided to get more actively involved in the newly acquired Indian unit. Read More
The Delhi High Court on Thursday reserved its order on the bail plea filed by Religare Finvest promoter Shivinder Mohan Singh in connection with a money laundering case. ...
Delhi High Court has granted regular bail to Religare Enterprises Limited Chief Financial Officer (CFO) Anil Saxena in connection with a case related to alleged siphoning of funds to the tune of Rs 2,000 crore from the company. ...
A Delhi court on Friday sent former Fortis Healthcare promoter Shivinder Mohan Singh to the custody of the Enforcement Directorate (ED) till December 19 in a money laundering case related to alleged misappropriation of funds at Religare Finvest Ltd ( ...